1,2,4-triaminobenzene N¹,N²-diacetate | 22177-15-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 1,2,4-triaminobenzene N¹,N²-diacetate
• 英文别名: N,N'-(4-amino-1,2-phenylene)bis[acetamide]；N¹,N²-diacetyl-1,2,4-triaminobenzene；N,N'-(4-amino-1,2-phenylene)diacetamide；3,4-Diacetylamino-anilin；N,N'-(4-amino-o-phenylene)-bis-acetamide；N,N'-(4-Amino-o-phenylen)-bis-acetamid；4-amino-N,N'-diacetyl-o-phenylene diamine；4-Amino-N.N'-diacetyl-o-phenylendiamin；4-Amino-1.2-bis-acetamino-benzol；N-(2-acetamido-4-aminophenyl)acetamide
• CAS: 22177-15-7
• 化学式: C₁₀H₁₃N₃O₂
• 分子量: 207.232
• InChiKey: VHUMGVTZFIBLPU-UHFFFAOYSA-N

物化性质

• 沸点：
  415.2±35.0 °C(Predicted)
• 密度：
  1.312±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  -0.4
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  84.2
• 氢给体数：
  3
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1,2,4-triaminobenzene N¹,N²-diacetate 在 盐酸 、 sodium acetate 、 溶剂黄146 作用下， 生成 5-氨基-2-甲基苯并咪唑
  参考文献：
  名称：

  Phillips, Journal of the Chemical Society, 1928, p. 174

  摘要：

  DOI：
• 作为产物：
  描述：

  邻氨基乙酰苯胺 在 异戊醇 、 硫酸 、 水 、 硝酸 、 铁粉 、 溶剂黄146 作用下， 生成 1,2,4-triaminobenzene N¹,N²-diacetate
  参考文献：
  名称：

  Phillips, Journal of the Chemical Society, 1928, p. 174

  摘要：

  DOI：

文献信息

• Generation of Cu nanoparticles on novel designed Fe₃O₄@SiO₂/EP.EN.EG as reusable nanocatalyst for the reduction of nitro compounds
  作者：Maryam Rajabzadeh、Hossein Eshghi、Reza Khalifeh、Mehdi Bakavoli

  DOI：10.1039/c5ra26020e

  日期：——

  Reusable magnetic Cu nanocatalyst was designed and characterized. An efficient and mild method for the reduction of aromatic nitro compounds.

  可重复使用的磁性铜纳米催化剂被设计并表征。一种高效而温和的方法用于还原芳香族硝基化合物。
• Pharmaceutically active 1,2,4-triamino-benzene derivatives, processes
  申请人：Asta Medica Aktiengesellschaft

  公开号：US05384330A1

  公开（公告）日：1995-01-24

  Pharmacologically active 1,2,4-triaminobenzene derivatives of the General Formula I: ##STR1## where the symbols R1' R2' R3' R4' R5' Ar and Alk have the following meanings: where the symbols R.sub.1, R.sub.2, R.sub.3, R.sub.4, R.sub.5, Ar and Alk have the following meanings: R.sub.1 : hydrogen, C.sub.1 -C.sub.6 -alkyl, C.sub.2 -C.sub.6 -alkanoyl or the radical Ar; R.sub.2 : hydrogen or C.sub.1 -C.sub.6 -alkyl; R.sub.3 : C.sub.1 -C.sub.6 -alkoxy, NH.sub.2, C.sub.1 -C.sub.6 -alkylamino, C.sub.1 -C.sub.6 -dialkylamino, amino substituted by the radical Ar, C.sub.1 -C.sub.6 -alkyl, C.sub.2 -C.sub.6 -alkenyl, C.sub.2 -C.sub.6 -alkynyl, the radical Ar or the radical ArO--; R.sub.4 : hydrogen, C.sub.1 -C.sub.6 -alkyl or the radical Ar; R.sub.5 : hydrogen or C.sub.1 -C.sub.6 -alkyl or the radical Ar; Alk: a straight or branched alkylene group containing 1-9 carbon atoms, which can also be substituted by the radical Ar.

  通用公式I的药理活性1,2,4-三氨基苯衍生物：其中符号R1'，R2'，R3'，R4'，R5'，Ar和Alk具有以下含义：其中符号R.sub.1，R.sub.2，R.sub.3，R.sub.4，R.sub.5，Ar和Alk具有以下含义：R.sub.1：氢，C.sub.1 -C.sub.6-烷基，C.sub.2 -C.sub.6-酰基或基团Ar；R.sub.2：氢或C.sub.1 -C.sub.6-烷基；R.sub.3：C.sub.1 -C.sub.6-烷氧基，NH.sub.2，C.sub.1 -C.sub.6-烷基氨基，C.sub.1 -C.sub.6-二烷基氨基，被基团Ar取代的氨基，C.sub.1 -C.sub.6-烷基，C.sub.2 -C.sub.6-烯基，C.sub.2 -C.sub.6-炔基，基团Ar或基团ArO-；R.sub.4：氢，C.sub.1 -C.sub.6-烷基或基团Ar；R.sub.5：氢或C.sub.1 -C.sub.6-烷基或基团Ar；Alk：含有1-9个碳原子的直链或支链烷基基团，也可以被基团Ar取代。
• Labelling of Carbaboranyl Compounds with a Selenium Atom with a View to Applications in Boron-Neutron-Capture Therapy (BNCT) and Positron-Emission Tomography (PET)
  作者：Deborah F. dos Santos、Mario Argentini、Regin Weinreich、Hans-Jürgen Hansen

  DOI：10.1002/1522-2675(20001108)83:11<2926::aid-hlca2926>3.0.co;2-6

  日期：2000.11.8

  We synthesized 2'-carbaboranyl-2,5'-bi-1H-benzimidazoles containing 10 B-atoms and labeled with Se or the positron-emitting radionuclide Se-73 (t(1/2) = 7.1 h), with a view to their application to cancel. treatment by boron-neutron-capture therapy (BNCT) and to compound-distribution measurements in vivo by positron-emission tomography (PET). Thus, 2,2'-[2'-(4-[1,2-dicarba-closo-dodecaboran(12)-2-ylmethoxy]phenyl]-[2,5'-bi-1H-benzimidazol]-5-yl}imino)bis[ethanol] (26c) was obtained by the reaction of 2,2'-[(3,4-diaminephenyl)imino]bis[ethanol] (19) with ethyl 2-4-[1,2-dicarba-closo-dodecaboran(12)-2-ylmethoxy]phenyl}-1H-benzimidazole-5-carboximidate hydrochloride (25), as well as the analogues 26a and 26b (Scheme 6). Tosylation of compound 26c gave 4 regioisomers 27a-d, which, after selenation, produced 2'-4-[1,2-dicarba-closo-dodecaboran(12)-2-ylmethoxy]phenyl}-5-(tetrahydro-2H-1,4-selenazin-4-yl)-2,5'-bi-1H-benzimidazole (29) in 42% yield (Scheme 7).
• Neue 1,2,4-Triaminobenzol-Derivate und Verfahren zu deren Herstellung
  申请人：ASTA Medica Aktiengesellschaft

  公开号：EP0554543B1

  公开（公告）日：1996-02-28
• Phillips, Journal of the Chemical Society, 1928, p. 174
  作者：Phillips

  DOI：——

  日期：——